Eph receptor tyrosine kinases play key roles in pattern formation during embryonic development, but little is known about the mechanisms by which they elicit speci®c biological responses in cells. Here, we investigate the role of tyrosines 605 and 611 in the juxtamembrane region of EphB2, because they are conserved Eph receptor autophosphorylation sites and demonstrated binding sites for the SH2 domains of multiple signaling proteins. Mutation of tyrosines 605 and 611 to phenylalanine impaired EphB2 kinase activity, complicating analysis of their function as SH2 domain binding sites and their contribution to EphB2-mediated signaling. In contrast, mutation to the negatively charged glutamic acid disrupted SH2 domain binding without reducing EphB2 kinase activity. By using a panel of EphB2 mutants, we found that kinase activity is required for the changes in cell-matrix and cell ± cell adhesion, cytoskeletal organization, and activation of mitogen-activated protein (MAP) kinases elicited by EphB2 in transiently transfected cells. Instead, the two juxtamembrane SH2 domain binding sites were dispensable for these eects. These results suggest that phosphorylation of tyrosines 605 and 611 is critical for EphB2-mediated cellular responses because it regulates EphB2 kinase activity.
Introduction
The Eph family of receptor tyrosine kinases, together with their ephrin ligands, regulate axon path®nding, cell migration, and cell segregation in the developing embryo (Drescher, 1997; Pasquale, 1997; BruÈ ckner and Klein, 1998; Flanagan and Vanderhaegen, 1998) . The signaling pathways that mediate these activities of the Eph receptors are largely unknown. As with other receptor tyrosine kinases, binding of their ligands, the ephrins, leads to autophosphorylation of tyrosine residues in the Eph receptor cytoplasmic domain . Tyrosine phosphorylation aects in at least two ways the signaling properties of receptor tyrosine kinases. First, addition of phosphate to certain tyrosine residues, which are typically located in the kinase domain, modi®es the local structure of the receptor. For example, conformational changes caused by phosphorylation of the`activation segment' stabilizes the activated conformation of the kinase domain (Yamaguchi and Hendrickson, 1996; Hubbard, 1997; Hubbard et al., 1998) . Second, phosphorylation of tyrosine-containing sequence motifs, which are typically located outside the kinase domain, transforms them into high-anity binding sites for the Src Homology 2 (SH2) or phosphotyrosine binding (PTB) domains of signaling proteins (Pawson and Scott, 1997) . The assembly of protein complexes mediated by phosphorylated tyrosines of activated receptor tyrosine kinases, therefore, favors functional interactions that are important for the activation of downstream signaling pathways (Fantl et al., 1992; van der Geer et al., 1994) .
Because each phosphorylated tyrosine, together with the amino acids that surround it, is selectively recognized by only some SH2 or PTB domains, many receptor tyrosine kinase signaling pathways are strictly dependent on speci®c autophosphorylated tyrosines (van der Geer et al., 1994) . These pathways can be identi®ed because they are selectively inactivated when those tyrosines are mutated, thereby preventing binding of eector proteins containing SH2 or PTB domains. In the platelet-derived growth factor (PDGF) receptor b, for example, phosphorylation of tyrosines 740 and 751 mediates binding of phosphatidylinositol (PI) 3-kinase, whereas phosphorylation of tyrosines 1009 and 1021 mediates binding of phospholipase C g (PLCg) (Escobedo et al., 1991; Fantl et al., 1992) . Mutagenesis experiments in which tyrosines of the PDGF receptor were changed to phenylalanine, have shown that both PI 3-kinase and PLCg are required to mediate the chemotactic signals of the PDGF receptor (Kundra et al., 1994) . Conversely, phosphorylation of a third tyrosine, tyrosine 771, which mediates binding of Ras GTPase activating protein (RasGAP), has been shown to suppress the chemotactic responses mediated by the PDGF receptor (Kundra et al., 1994) . Another example is tyrosine 766 in ®broblast growth factor (FGF) receptor 1, which binds PLCg and whose deletion selectively abolishes phosphatidylinositol hydrolysis but not mitogenesis in L6 myoblasts and neuronal dierentiation in PC12 cells (Peters et al., 1992; Spivak-Kroizman et al., 1994) .
Two conserved tyrosines in the membrane-proximal (juxtamembrane) region of Eph receptors are likely to play a key role in mediating the biological activities of Eph receptors. They are major autophosphorylation sites of and, when phosphorylated, form docking sites for multiple SH2 domain-containing proteins. These tyrosines have been reported to bind the SH2 domains of the kinases Fyn (Ellis et al., 1996) and Src (Zisch et al., 1998) , RasGAP (Holland et al., 1997; Hock et al., 1998a) , and the adaptor proteins Nck (Stein et al., 1998a) and Crk (Hock et al., 1998a) . In EphB2, they correspond to tyrosines 605 and 611.
To investigate their role in Src binding, we have previously mutated tyrosines 605 and 611 of EphB2 to the closely related amino acid phenylalanine, which cannot be phosphorylated (Zisch et al., 1998) . Tyrosine to phenylalanine mutagenesis has been used extensively to investigate the function of autophosphorylation sites of tyrosine kinases (van der Geer et al., 1994) , including Eph receptors (Ellis et al., 1996; Holland et al., 1997; Hock et al., 1998a; Stein et al., 1996 Stein et al., , 1998a . Replacing tyrosines 605 and 611 in EphB2 with phenylalanine, however, impaired EphB2 kinase activity (Zisch et al., 1998) . This impairment in kinase activity complicates analysis of the function of the two tyrosines as SH2 domain binding sites. Here we report an alternative approach, which allows mutagenesis of tyrosines 605 and 611 without abrogating EphB2 kinase activity. This approach may be also useful for establishing the role of other receptor autophosphorylation sites when their mutation to phenylalanine aects kinase activity.
Results
Phenylalanine residues at positions 605 and 611 impair EphB2 kinase activity whereas glutamic acid residues preserve kinase activity
To analyse the role of phosphorylation of tyrosines 605 and 611 in mediating the biological activities of EphB2, we transiently transfected COS cells with a panel of EphB2 mutants in which either tyrosine 605, or 611, or both, were mutated to phenylalanine. As we have shown (Zisch et al., , 1998 , transient transfection of wild type EphB2 in a variety of cell lines results in expression of activated EphB2. Immunoblotting cell extracts with anti-phosphotyrosine antibodies showed that the phenylalanine mutations impaired EphB2 kinase activity (Figure 1 ). This was particularly evident from the poor phosphorylation of cellular proteins by the EphB2Y605/611F double mutant, re¯ecting the weak kinase activity of the mutant receptor towards substrates and possibly also greatly reduced activation of downstream tyrosine kinases.
In an attempt to eliminate the two SH2 domain binding sites while preserving kinase activity, we replaced tyrosines 605 and 611 with glutamic acid residues. The negative charge of the autophosphorylated tyrosines in activated EphB2, and that of glutamic acid, may be important for kinase activity. We indeed observed that EphB2 with the glutamic acid mutations retained high kinase activity (Figure 1) . In COS cells expressing EphB2Y605/611E, tyrosine phosphorylation of both the receptor and cellular proteins was substantial compared to cells expressing wild type EphB2. Similar results were obtained with 293 human embryonal kidney cells (not shown). These experiments demonstrated that mutation of tyrosines 605 and 611 to phenylalanine, but not glutamic acid, severely impairs overall EphB2 kinase activity towards itself and substrate proteins. Therefore, tyrosine to glutamic acid mutants of EphB2 can be used to discriminate EphB2-mediated cellular eects that depend on the two juxtamembrane SH2 domain binding sites from the eects that depend on kinase activity and/or the phosphorylation of tyrosines other than tyrosines 605 and 611.
The phosphorylated tyrosine 605 and 611 motifs both represent binding sites for the SH2 domain of Src
In our previous yeast two-hybrid analyses of the interaction between EphB2 and the SH2 domain of the Src kinase (Zisch et al., 1998) , we used EphB2 receptors in which tyrosines 605 and 611 had been mutated to phenylalanine. Since mutation of tyrosine 611 to phenylalanine was sucient to abolish binding of the Src SH2 domain, we concluded that tyrosine 611 of EphB2 is a major binding site for the Src SH2 domain (Zisch et al., 1998) . The drastic dierence in kinase activity and overall phosphorylation between EphB2Y611F and EphB2Y611E transfected in mammalian cells (Figure 1 ), however, led us to re-examine the binding between the Src SH2 domain and EphB2.
Yeast two-hybrid assays demonstrated that when tyrosine 611 is mutated to glutamic acid, EphB2 still binds the Src SH2 domain (Figure 2a ). When tyrosines 605 and 611 were simultaneously mutated to glutamic acid, however, binding of the Src SH2 domain was undetectable. In vitro kinase reactions with the LexA:EphB2 fusion proteins used for two-hybrid Figure 1 Phenylalanine and glutamic acid residues at positions 605 and 611 dierentially aect EphB2 autokinase activity and overall cellular tyrosine phosphorylation. Equal amounts of COS cell extracts were probed by immunoblotting with antiphosphotyrosine antibodies (PTyr), to evaluate the level of autophosphorylation of the transfected EphB2 and overall phosphorylation of cellular proteins, and reprobed with antibodies to EphB2 to verify the level of EphB2 expression. The position of EphB2 is indicated on the left by an arrow. Wild type and mutated forms of EphB2 are indicated at the bottom. Sizes of molecular weight markers, in Kd, are indicated at right analyses con®rmed that EphB2Y605/611E autophosphorylated to a similar extent as the wild type ( Figure  2b ). This is in contrast to the barely detectable levels of autophosphorylation that we had previously detected for LexA:EphB2Y605/611F (Zisch et al., 1998) .
From these results we infer that the sequence motif containing phosphorylated tyrosine 605 can function as an additional binding site for Src. The observed lack of interaction between EphB2Y611F and the Src SH2 domain (Zisch et al., 1998; Figure 2a) We veri®ed that the full-length EphB2Y605/611E expressed in 293 cells is impaired in its ability to bind the Src SH2 domain by measuring association with a GST fusion protein of the Src SH2 domain ( Figure  4a ). Furthermore, a GST fusion protein containing the two SH2 domains of RasGAP, which were previously shown to bind to tyrosines 605 and 611 of EphB2 (Holland et al., 1997) , also bound wild type EphB2 and not EphB2Y605/611E. The association of EphB2 with the RasGAP SH2 domains, however, appears to be weaker than that with the Src SH2 domain because it was observed only under more mild detergent conditions (Figure 4 legend). The SH2 domain of the adaptor Crk, which was previously shown to interact with the EphB3 receptor (Hock et al., 1998a) , bound wild type EphB2 and EphB2Y605/611E to a similar extent, indicating that Crk binds to phosphorylated sequence motifs dierent from tyrosines 605 and 611.
These results show that even in the absence of physical recruitment of downstream signaling proteins to the tyrosine 605 or 611 binding sites, downstream signaling pathways are activated at sucient levels to cause cell rounding. To further examine the role of Src in mediating cell rounding downstream of EphB2, we transfected EphB2 in mouse 3T3 cells that do not contain Src (Thomas et al., 1995) . These experiments demonstrated that Src is not required for EphB2-induced cell rounding, because EphB2 caused similar levels of 3T3 cell rounding in the absence and in the presence of co-transfected Src (Figure 4b ).
Role of tyrosines 605 and 611 in EphB2-mediated actin cytoskeleton reorganization
Results from recent studies addressing the eects of cell ± cell contact involving Eph receptor-ephrin ligand interactions have indicated that cells expressing Eph receptors are actively repelled from regions of high ligand expression (reviewed by Drescher, 1997; Pasquale, 1997; BruÈ ckner and Klein, 1998; Flanagan and Vanderhaegen, 1998) . However, we have previously reported that EphB2 expressing retinal neurons attach to surfaces coated with the ephrin-B1 ligand (Holash et al., 1997) , suggesting that ephrin-B1, at least when isolated from its native cellular environment, can promote adhesive interactions. As shown in Figure  5c ,d, 293 cells expressing wild type EphB2 indeed attached and spread extensively on ephrin-B1 coated surfaces, allowing us to examine their actin cytoskeleton organization. Staining for ®lamentous (F)-actin revealed an unusual morphology, with a characteristic organization of F-actin into ring-like structures (Figure 5c ). Prominent F-actin-containing radial protrusions resembling long ®lopodia extended outwards from the actin ring, with a symmetric organization around the cell periphery.
Like the cells expressing wild type EphB2, the cells transfected with the kinase inactive EphB2K662R selectively attached to ephrin-B1 (Figure 5e,f) . This indicates that the interaction between the EphB2 and ephrin-B1 ectodomains was sucient to mediate attachment, even in the absence of EphB2-mediated signals. The cells expressing EphB2K662R, however, had a polygonal shape clearly dierent from the unpolarized circular shape of cells expressing wild type EphB2. There were also fewer ®lopodia and lamellipodia-like protrusions in the EphB2K662R-expressing cells. These results suggest that signals mediated by EphB2 in response to adhesion to ephrin-B1 ligand coated on the substrate cause distinctive reorganization of the actin cytoskeleton. Cells transfected with EphB2Y605/611E were indistinguishable from cells transfected with wild type EphB2 (Figure 5i ,j), whereas EphB2Y605/611F caused a phenotype similar to that of kinase inactive EphB2 (Figure 5g ,h). Thus, it appears that the changes in the actin cytoskeleton that require kinase activity do not require tyrosines 605 and 611 as sites for recruitment of SH2 domain-containing eector proteins.
Cells expressing wild type EphB2 were mostly present as single cells ( Figure 5 ) and did not form cell ± cell junctions, which are normally observed in the 293 cells. In contrast, control transfected cells and cells expressing EphB2K662R and EphB2Y605/611F, two mutants that are de®cient in kinase activity, formed cell ± cell contacts which were labeled with rhodaminephalloidin (arrows in Figure 5 ). This suggests that the expression of activated EphB2 disrupted the organization of cell ± cell junctions and that EphB2 kinase activity was required for this eect.
Role of tyrosines 605 and 611 in EphB2-mediated activation of MAP kinases
The morphological changes observed in cells expressing activated EphB2 suggest that small GTPases of the Ras superfamily are downstream of EphB2. For example, activation of R-Ras activates integrins (Zhang et al., 1996; Zou et al., in press) , whereas activation of H-Ras inactivates them (Hughes et al., 1997) ; and Ras and Rac play a role in regulating cell ± cell adhesion (Potempa and Ridley, 1998) . Furthermore, activation of Cdc42 and Rac could be responsible for the formation of circumferential membrane protrusions in the EphB2 transfected cells adhering to ephrin-B1. Because activation of small GTPases is typically re¯ected in the downstream activation of various mitogen-activated protein (MAP) kinases (Quilliam et al., 1995) , we have investigated whether EphB2 causes changes in extracellular signal-regulated kinase (Erk) and c-Jun N-terminal kinase (JNK) activation. Erk2 and JNK-1 immunoprecipitated from transfected 293 cells expressing activated EphB2 had enhanced kinase activity towards substrate proteins compared to Erk2 and JNK-1 from control cells (Figure 6 ). EphB2 kinase activity, but not the presence of tyrosines 605 and 611, was required for activation of both Erk2 and JNK-1. This is consistent with the hypothesis that EphB2 Cells derived from Src knock out mice were transfected with EphB2, Src, or EphB2 together with Src. Empty vector (pcDNA3) was used as a control. An EGFP vector was co-transfected at a ratio of 1 : 10 to identify the transfected cells activates signaling pathways that, presumably through the activation of various Ras superfamily GTPases, lead to cytoskeletal reorganization, decreased cell adhesion, and activation of MAP kinases. EphB2 kinase activity, but not the binding of SH2 domains to tyrosines 605 and 611, is required for these eects to occur in the transiently transfected cells.
Discussion
Signals transduced by the activated EphB2 receptor decrease cell adhesion to extracellular matrix proteins and cell ± cell adhesion, cause actin reorganization in cells adhering to ephrin-B1 substrates, and activate MAP kinases. We have used these screenable EphB2-mediated eects in combination with site-directed mutagenesis to dissect the role of tyrosines 605 and 611 in EphB2 receptor signaling.
Amino acid substitutions at positions 605 and 611 in¯uence EphB2 kinase activity Although tyrosines 605 and 611 are outside the kinase domain, conservative mutations to phenylalanine substantially decreased EphB2 kinase activity in vitro (Zisch et al., 1998) as well as in cells. As we have shown, these mutations result in a dramatic decrease in both reactivity towards exogenous substrates and phosphorylation of the EphB2 receptor itself. The activities of several other receptor tyrosine kinases, including the PDGF receptor, Fms, hepatocyte growth factor receptor, and epidermal growth factor receptor, are sensitive to amino acid substitutions and phosphorylation in the juxtamembrane segment (Davis, 1988; Mori et al., 1993; Gandino et al., 1994; Myles et al., 1994) .
The reasons for the detrimental eects of the juxtamembrane tyrosine to phenylalanine mutations on EphB2 activity could be twofold. First, replacement of the tyrosines with phenylalanine may cause structural changes that are incompatible with EphB2 activation. Second, phosphorylation of tyrosines 605 and 611, which occurs in vitro (Zisch et al., 1998) as well as in transfected cells (Kalo and Pasquale, unpublished data) , may be required for full kinase activity. A regulatory role of phosphorylation at these sites would be consistent with our results showing that replacing the two juxtamembrane tyrosines with phenylalanine, which cannot be phosphorylated, yields an inactive receptor, whereas replacing them with glutamic acid, which like phosphotyrosine is negatively charged, yields an active receptor. Acidic amino acids have been shown to ful®ll some of the functions Figure 5 EphB2 tyrosine kinase activity is required for F-actin rearrangement in cells adhering on an ephrin-B1-coated substrate, whereas the tyrosine 605 and 611 SH2 domain binding sites are dispensable. The 293 cells were transiently transfected with EGFP alone (EGFP), or co-transfected with EGFP and the indicated wild type or mutated forms of EphB2. One day after transfection, the cells were plated on coverslips coated with anti-Fc antibodies followed by ephrin-B1 Fc. Transfected cells were identi®ed because of EGFP¯uorescence (b,d,f,h,j) . The organization of the actin cytoskeleton was visualized by staining with rhodamine-phalloidin (a,c,e,g,i). Cells lacking EphB2 (EGFP) did not attach to the ephrin-B1 substrate or attached poorly as multicellular clumps containing both transfected and untransfected cells (b). Cells expressing activated EphB2 (WT, EphB2Y605/611E) exhibit a ring of actin from which actin-containing radial projections extend symmetrically all around the cell periphery. In contrast, cells expressing kinase inactive EphB2 (K662R, Y605/611F) have a more polarized morphology with fewer actin-containing projections. Cells expressing activated EphB2 also have disrupted cell ± cell junctions, whereas in cells lacking activated EphB2 (EGFP, K662R, Y605/ 611F) cell ± cell junctions are present and exhibit a concentration of actin (see arrows in a,g). Cells were photographed under a 1006objective of a phosphorylated residue (Thorsness and Koshland, 1987; Kaufman et al., 1989; Wittekind et al., 1989; Waldmann et al., 1990; Huang and Erikson, 1994) . The lack of interaction between EphB2Y605/611E and the Src SH2 domain, however, demonstrated that a glutamic acid residue cannot replace a phosphorylated tyrosine in an SH2 domain binding site.
Like EphB2, the PDGF receptor contains two autophosphorylation sites in the juxtamembrane segment, which are also binding sites for the Src SH2 domain (Mori et al., 1993) . The consequences of abrogating Src binding to the PDGF receptor could not be studied, however, because the double mutation to phenylalanine eliminated not only Src binding, but also kinase activity (Mori et al., 1993) . Other examples have been reported where mutation of regulatory tyrosines to phenylalanine inhibited kinase activity thereby complicating the interpretation of mutational studies (Courtneidge et al., 1991 . A mutagenesis approach in which tyrosines were replaced with glutamic acid enabled us to study the signaling properties of an EphB2 receptor mutant that lacks the two juxtamembrane binding sites for SH2 domains, while kinase activity and phosphorylation of other sites in the cytoplasmic domain are preserved.
Binding of eector proteins to tyrosines 605 and 611 is dispensable for EphB2-mediated changes in cell morphology and MAP kinase activation in transfected cells
Tyrosines 605 and 611 both bind the SH2 domain of the Src kinase, consistent with their being part of sequence motifs (Y 605 IDP and Y 611 EDP) that are similar to one another. Provided that kinase activity was preserved, however, even simultaneous mutation of both tyrosines did not change the EphB2-mediated biological responses that we observed in transfected 293 cells. Thus, binding of SH2 domain-containing proteins ± such as Src ± to tyrosines 605 and 611 is not essential for these biological responses. Furthermore, EphB2 caused rounding of Src-de®cient cells, indicating that Src is not required for the cell rounding response.
The main contribution of autophosphorylation at tyrosines 605 and 611 to EphB2 function may be to regulate kinase activity, whereas other binding sites may be more important for mediating interactions with eector molecules. The high level of autophosphorylation of EphB2Y605/611E, which lacks both tyrosine 605 and 611, con®rmed our phosphopeptide analyses showing that additional autophosphorylation sites are present in EphB2 (Zisch et al., 1998; Kalo and Pasquale, 1999) . These additional sites could bind eector proteins that couple EphB2 to changes in cell morphology and MAP kinase activation. Such eector proteins may include the adaptor Crk, as we have shown here, the adaptors Grb2 and Grb10 (Stein et al., 1996) , phosphatidylinositol (PI) 3-kinase , and a low molecular weight phosphatase (LMW-PTP) (Stein et al., 1998b) . A role of LMW-PTP in mediating changes in cell adhesion downstream of EphB receptors has indeed been proposed (Stein et al., 1998b) . EphB2 signals may also be propagated by the Ras binding protein AF6 and other PDZ domaincontaining proteins, which bind to the C-terminus of Eph receptors (Hock et al., 1998b; Buchert et al., 1999; Torres et al., 1999) .
It is also possible that parallel (redundant) signaling pathways simultaneously contribute to the morphological changes in EphB2-expressing cells. If activation of several EphB2-mediated signaling pathways converge to cause the same biological response, it will be necessary to simultaneously inactivate all of them to abrogate the response, particularly under conditions of high EphB2 expression. Redundant signaling pathways have been described for the TrkA receptor, which mediates Ras and Erk1 activation through binding of the adaptor Shc to tyrosine 490 as well as through binding of PLCg to tyrosine 785 (Stephens et al., 1994) . Only TrkA receptors lacking both binding sites failed to stimulate neurite extension and induce Erk1 activity.
Some of the proteins that interact with tyrosines 605 and 611 could also function as negative regulators of the eects observed upon forced expression of activated EphB2. RasGAP, for example, binds the phosphorylated tyrosine 605 and 611 motifs of EphB2 (Holland et al., 1997; Figure 4a) . Because it catalyzes hydrolysis of GTP bound to Ras, and therefore Ras inactivation, RasGAP is a negative regulator of Ras signaling pathways (Boguski and McCormick, 1993) . Similarly RhoGAP, a GTPase activating protein for Rho, associates with EphB2 through RasGAP and therefore also depends on tyrosines 605 and 611 for association (Holland et al., 1997) . Deletion of the binding sites for RasGAP and RhoGAP may therefore potentiate, rather than abrogate, activation of Ras superfamily signaling pathways.
Implication of ras superfamily GTPases and MAP kinases in EphB2-mediated cell morphological changes
The expression of activated EphB2 in 293 cells causes dramatic changes in cell morphology due at least in part to weakened adhesion to extracellular matrix proteins and compromised intercellular contacts. The molecular targets of EphB2 activity in 293 cells are only starting to be elucidated. As reported elsewhere (Zou et al., in press ), EphB2-mediated signals cause integrin inactivation. In the present study, we show that the two MAP kinases, Erk2 and JNK-1, are activated in cells expressing wild type EphB2. JNK activation also occurs downstream of a signaling cascade involving another Eph receptor, EphB1, and the adaptor protein Nck (Stein et al., 1998a) .
How activation of MAP kinases is coupled to the observed cellular responses is as yet unclear. Direct modi®cations of cytoskeletal elements as well as changes in gene transcription are possible. For instance, Erk1 and Erk2 kinases are associated with microtubules in vivo and can phosphorylate various microtubule-associated proteins (Reszka et al., 1995) . Furthermore Erk1, Erk2, and JNK phosphorylate KSP repeats in the tail domain of neuro®lament proteins (Veeranna et al., 1998; Giasson and Mushynski, 1996; . Together, phosphorylation of microtubules and neuro®laments by MAP kinases activated downstream of EphB2 may directly in¯uence cytoskeletal organization and neurite outgrowth and branching (Reszka et al., 1995; Veeranna et al., 1998; Mushynski, 1996, 1997) . Furthermore, MAP kinases have an established role as kinases that regulate the activity of several transcription factors (Treisman, 1996) . EphB2-initiated changes in gene transcription remain to be investigated.
Unlike integrin-mediated cell substrate adhesion, attachment of 293 transfectants to a substrate containing ephrin-B1, which is a high anity ligand for the EphB2 receptor, depends on EphB2. EphB2-mediated attachment to ephrin-B1 results in striking reorganization of the actin cytoskeleton, which is dependent on EphB2 kinase activity. This possibly re¯ects changes in the activities of small GTPases of the Rho family, which have well established roles in regulating the actin cytoskeleton (Mackay et al., 1995; Luo et al., 1997; Tapon and Hall, 1997) . The implication of small GTPases of the Ras superfamily in EphB2 signaling pathways is also consistent with the observed activation of MAP kinases (Quilliam et al., 1995) .
The radial membrane projections extending from the periphery of EphB2-expressing cells are reminiscent of ®lopodia and microspikes that contain the actin bundling protein fascin (Adams, 1995 (Adams, , 1997 . Furthermore, EphB2-transfected 293 cells adhering on ephrin-B1 have many characteristics in common with cells transfected with fascin (Yamashiro et al., 1998) , including the formation of circumferential membrane protrusions and a ring-like structure containing Factin, a¯attened morphology, and disorganization of intercellular junctions (Adams, 1997; Yamashiro et al., 1998) . The similar morphologies suggest that the eects of EphB2 are at least in part mediated by fascin or a similar actin bundling protein.
Filopodia and fascin-containing microspikes are typically found at the leading edge of motile cells (Adams et al., 1995; Lin et al., 1996) . The radial membrane protrusions in cells expressing wild type EphB2, however, could also represent retraction ®bers, similar to those observed at the trailing edge of migrating cells (Lauenburger and Horwitz, 1996; Mitchison and Cramer, 1996) . The formation of retraction ®bers in response to EphB2 ligand binding would be consistent with the known eects caused by Eph receptor activation, which include growth cone collapse, neurite retraction, and cell repulsion (Drescher et al., 1995; Meima et al., 1997a,b; Wang and Anderson, 1997) . Further characterization of the biochemical composition of membrane protrusions in EphB2 expressing cells is required to determine their identity as ®lopodia, fascin microspikes, retraction ®bers, or other actin-containing structures.
In conclusion, we have established in vitro models that allow us to study EphB2 signaling pathways. We have used 293 cells, a human kidney cell line with mesenchymal properties. The 293 cells do not appear to contain endogenous Eph receptors that bind the ligands ephrin-B1, as reported here, and ephrin-A1 (Nakamoto et al., 1996) . By using speci®c antibodies, we have not detected endogenous EphB2, EphB3, or EphA3 in 293 cells, although we have detected very low levels of EphB4 and EphA4 expression. Thus, it is unlikely that endogenous Eph receptors transduce signals by heterodimerizing with the transfected EphB2. With these in vitro models, we were able to dissect the contribution of the juxtamembrane autophosphorylation sites to EphB2-mediated eects. Substitution of these juxtamembrane tyrosines with glutamic acid proved instrumental in unraveling features of EphB2 kinase regulation and signaling that can be predicted to be relevant for other receptor tyrosine kinases as well.
Materials and methods

Antibodies
Anity-puri®ed polyclonal antibodies to b-galactosidaseEphB2 and glutathione S-transferase (GST)-EphB2 were generated as described previously (Pasquale, 1991; Holash and Pasquale, 1995) . Antibodies to the extracellular domain of EphB2 were generated using as the antigen an EphB2 Fc chimeric protein (Shao et al., 1994) puri®ed with protein-A agarose from 293T cell culture supernatants containing low Ig serum. The anti-EphB2 Fc immune serum was puri®ed on an A-Gel 10 anity column containing the EphB2 Fc protein and absorbed on a human Fc column (Cappel). Horseradish conjugated anti-phosphotyrosine antibody PY20 was from Transduction Laboratories.
Plasmids
The yeast two-hybrid plasmids LexA:EphB2, LexA: EphB2Y605F, LexA:EphB2Y611F, LexA:EphB2Y605/611F, and LexA:EphB2K662R have been described (Zisch et al., 1998) . LexA:EphB2 plasmids with tyrosine to glutamic acid mutations were generated as follows. LexA:EphB2Y605/611E was generated by PCR-based mutagenesis using LexA:EphB2 as template, partially overlapping primers in which the codons encoding both tyrosines are mutated, and two external primers. The sequence of the forward mutagenesis primers is GATTGAGATCGATCCATTTACCGAAGAAG and that of the reverse primer is CTTCTTCGGTAAATG-CTCAATCT (mutated nucleotides are underlined). A BamHI to EcoRV fragment of LexA:EphB2 was replaced with the corresponding ampli®ed fragment containing the Y605E and Y611E mutations. LexA:EphB2Y605/611E was obtained in the same experiment as an unexpected product. LexA: EphB2Y611E was generated by replacing a Bsp106I to DraIII fragment of LexA:EphB2 with the corresponding fragment containing the Y611E mutation.
To obtain full length EphB2K662R, EphB2Y611F, or EphB2Y611E in pcDNA3, Bsp106I to HpaI restriction fragments were excised from the LexA:EphB2 yeast two hybrid plasmids containing the corresponding mutations and ligated into Bsp106I and HpaI digested EphB2-pcDNA3. To obtain full length EphB2Y605F in pcDNA3, we performed a PCR ampli®cation using EphB2-pcDNA3 as the template, the T7 primer as forward primer and the mutated GATCGATAAAAATCTTCATGGG primer as a reverse primer (mutated nucleotide is underlined). A BspEI to Bsp106I fragment obtained from the PCR product, and containing the Y605F mutation, was ligated into BspEI and Bsp106I digested EphB2-pcDNA3. The same fragment was ligated into BspEI and Bsp106I digested EphB2Y611F-pcDNA3 to obtain EphB2Y605/611F. To generate EphB2Y605E and EphB2Y605/611E in pcDNA3, we performed a PCR ampli®cation using as the template EphB2Y611E in pcDNA3, the T7 primer as forward primer, and the reverse primer with the Y605/611E double mutation. The PCR fragment was digested with BspEI and Bsp106I and ligated into BspEI and Bsp106I digested EphB2-pcDNA3 and EphB2Y611E-pcDNA3, respectively. The fragments generated by PCR were completely sequenced. The pGEX1-Crk SH2 domain comprises amino acids 238 ± 368 of avian sarcoma virus CT10 (GenBank accession number y00302). The Src-pcDNA3 plasmid has been described (Zisch et al., 1998) .
Cell culture and transfection
COS-7 cells, 293 cells, and 3T3 cells from Src knock out mice (Thomas et al., 1995) were grown in Dulbecco's minimal essential medium supplemented with pyruvate and containing 10% fetal bovine serum (DMEM/FCS). Transfections were performed with either SuperFect Transfection Reagent (Qiagen) following the manufacturer's instructions, or with the modi®ed calcium-phosphate-mediated transfection method using N,N-bis(2-hydroxyethyl)-2-aminoethanesulfonic acid (BES) (Calbiochem) buered saline. Cells 50 ± 80% con¯uent were transfected with 0.3 mg DNA per cm 2 . For calcium phosphate-mediated transfections, cells were incubated with the DNA transfection mix either for 6 h or overnight. For transfections with SuperFect reagent, cells were incubated with DNA/SuperFect for 2 h. The transfection mix was then removed and replaced with fresh DMEM/FCS.
Plating of EphB2 transfected 293 cells on ephrin-B1 substrate
The generation and puri®cation of ephrin B1-Fc protein and the preparation of ephrin B1-Fc-coated substrates have been described previously (Holash et al., 1997) . Brie¯y, glass coverslips were precoated with anti-Fc antibodies by incubating them with 10 mg/ml goat anti-human Fc antibody (Cappel) for 2 h at 378C in the wells of 24 wells plates. After rinsing with PBS, they were incubated with a 30 mg/ml solution of ephrin B1-Fc protein in PBS overnight at 378C. Coverslips were then stored in the ephrin-B1 solution for 2 days at 48C. Prior to plating the cells, the ephrin B1 solution was removed and the plates were treated with 1% BSA in PBS for 80 min at 378C. Control coverslips were coated with BSA only. Finally, the plates were rinsed with PBS.
293 cells were seeded in 12-well culture plates and grown overnight to about 60% con¯uency. The cells were transfected with a 10 : 1 (mg/mg) mixture of EphB2-pcDNA3 and pEGFP-N2 using the calcium phosphate-mediated transfection procedure. After 6 h, the DNA transfection mix was removed and replaced with DMEM/FCS. Eighteen hours after addition of DNA, the cells were harvested by trypsinization, transferred into DMEM/FCS, pelleted by short centrifugation and resuspended in 4 ml of plain DMEM. 2 ml of the cell suspension were then transferred to wells containing either ephrin-B1-coated or BSA-coated (control) coverslips and incubated for 30 min at 378C. Nonattached cells were removed by three careful washes with PBS and the culture medium replaced. Microscopic monitoring of the cells under UV light veri®ed the selective attachment of EphB2 expressing transfectants (identi®ed through the co-transfected EGFP) to ephrin B1 substrate, but not to BSA-coated control coverslips. Eighteen hours after plating, the cells were stained for actin and examined bȳ uorescence microscopy.
Fluorescence microscopy
Live transfected cells were photographed using a Zeiss Axiovert¯uorescence microscope. For actin staining, transfected cells grown on glass coverslips were ®xed in 4% paraformaldehyde for 20 min, washed twice with PBS, then incubated with 100 mM glycine in PBS for 10 min, followed by 1% bovine serum albumin in Tris buered saline for 20 min. Cells were rinsed twice with PBS, then permeabilized for 2 min with 0.2% Triton X-100. After three additional washes with PBS, cells were incubated with a 1 : 500 dilution of rhodamine-labeled phalloidin (Molecular Probes) for 30 min. The cells were washed three times with PBS, mounted on slides and photographed using a Zeiss Axiovert¯uorescence microscope. Transfected Src-de®cient 3T3 cells were grown in tissue culture plates, ®xed with paraformaldehyde, and photographed with a Nikon Inverted E-300 Microscope equipped with a SPOT cooled color digital camera. Flat, round, and undetermined morphologies were evaluated in¯uorescence and phase contrast photographs of the same ®elds, and about 100 ± 150 cells were counted in each group. The transfected cells were identi®ed from their EGFP¯uorescence.
Binding assays with GST fusion proteins
Puri®cation of the GST-SH2 domain of Src and Crk was performed as described previously (Zisch et al., 1998) . A GST fusion protein comprising both SH2 domains of RasGAP and conjugated to agarose was purchased from Santa Cruz Biotechnology. To examine the interaction between EphB2 and the Src SH2 domain, wild type and mutant EphB2 receptors were expressed in 293 cells by transient transfection. Twenty-four hours after transfection, cells were scraped o the plate and harvested in ice cold PBS, collected by centrifugation, and immediately frozen on dry ice. All further steps were carried out at 48C. Cell pellets were resuspended, extracted in RIPA buer or 1% Brij buer on an Eppendorf mixer for 10 min (Zisch et al., 1998) , and clari®ed by centrifugation. The supernatants were precleared by incubation with glutathione-sepharose for 15 min on a rotating wheel, supplemented with DTT to a ®nal concentration of 5 mM, and incubated for 1 h with 15 ml of glutathione sepharose containing the GST-SH2 domains, or GST alone. After four washes with extraction buer, bound EphB2 receptors were eluted and detected by SDS ± PAGE and immunoblotting.
Immunoblotting
Proteins were separated on acrylamide gels, electrotransferred to polyvinyl di¯uoride membranes (PVDF) (Millipore) and stained with 0.2% Ponceau S. Membranes were blocked with either 3% BSA in Tris buered saline (TBS) (in case of subsequent probing with anti-phosphotyrosine antibodies), or 1.5% non-fat milk, 1.5% BSA in TBS. Incubations with primary antibodies were for 1 ± 3 h at room temperature and primary antibodies were used at 1 ± 3 mg/ml in blocking buer. Detection of the primary rabbit polyclonal antibodies was performed with protein A-peroxidase (Sigma) as secondary reagent and an enhanced chemiluminescence detection system (Amersham Life Science). In re-probing experiments, antibodies were stripped by a 30 min incubation at 508C with stripping buer (62.5 mM Tris, pH 7.5, 2% SDS, 100 mM mercaptoethanol). Membranes were then washed with TBS, blocked, and probed again with antibodies as described above.
Assays for interactions using the yeast two-hybrid system
Interactions between LexA:EphB2 and VP16: fusion proteins were detected based on the ability of the co-transformants to grow on THULL medium and on b-galactosidase activity, as previously described (Zisch et al., 1998) . In brief, for bgalactosidase assays co-transformed yeast were streaked on UTL medium, grown for 2 days, then replica plated on nitrocellulose ®lters and assayed for b-galactosidase activity. The colorimetric reaction was stopped after 20 min and photographed. To assess growth on histidine-free medium, co-transformed yeast were grown for 3 days on plates containing 15 mM 3-amino-1,2,4,-triazole and photographed.
In vitro kinase assays
In vitro kinase reactions with immunoprecipitated LexA:EphB2 proteins from lysates of transformed yeast were performed as described previously (Zisch et al., 1998) . For Erk2 and JNK-1 in vitro kinase assays, 293 cells were transfected 24 h after plating using SuperFect reagent and 2 mg total DNA/6 cm culture plate (Erk2 assays) or 10 mg total DNA/10 cm culture plate (JNK-1 assays). The DNA consisted of a 1 : 1 ratio of EphB2 in pcDNA3 and either pSRa-(HA) Erk2 (Minden et al., 1994) , encoding an HAtagged form of Erk2, or pCMV5-(M2) JNK1 , encoding a FLAG-tagged form of JNK-1. Twentyfour hours after transfection the cells were serum-starved for 24 h by growing them in DMEM without serum. The cells were then lysed in 0.6 ml lysis buer (50 mM HEPES, pH 7.6, 250 mM NaCl, 3 mM EGTA, 3 mM EDTA, 100 mM Na 3 VO 4 , 0.5% NP-40, 1 mM PMSF, 10 mg/ml leupeptin, and 10 mg/ml aprotinin), centrifuged in an Eppendorf microfuge at 14 000 r.p.m. for 10 min at 48C, and the total amount of protein in the lysates was determined by the Bradford method. Two ml anti-HA rabbit polyclonal antibodies (Y-11 Santa Cruz Biotechnology) or anti-FLAG mouse monoclonal antibodies (M2; Kodak/IBI) together with 20 ml of a 50% suspension of protein-A sepharose were added to supernatants containing equal amounts of protein to immunoprecipitate the transfected Erk2 or JNK-1, respectively. In vitro kinase reactions with either Erk2 and 1 mg myelin basic protein (Upstate Biotechnology) or JNK-1 and 1 mg GST-c-Jun (Stratagene) were carried out in the presence of 10 mM ATP and 1 mCi [g-32 P]ATP as previously described (Cavigelli et al., 1995) .
